Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|4|371-382

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.4, 2015-04, pp. : 371-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of myeloma in younger patients

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 1, 2015-01 ,pp. : 94-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myeloma therapy in older patients

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 335-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Guidelines on the management of AL amyloidosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 186-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 89, Iss. 5, 2014-05 ,pp. : 457-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medical Oncology Group of Australia‐Executive Committee

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S3, 2015-08 ,pp. : 3-3

John Wiley & Sons Inc

Access to resources Recommend Favorite